Grand Slam winners such as Iga Swiatek, Carlos Alcaraz, and Elena Rybakina have spoken out on the demands of the calendar across 2024. WTA players are currently expected to play at least twenty events ...

Iga Swiatek is preparing to make her return to tennis after an extended break and she is looking to finish the season on a high. Switaek has not played since losing at the US Open against Jessica ...

And it’s down to two women: Aryna Sabalenka and Iga Swiatek. Sabalenka's the favorite, coming into the year-end championships with 9,016 ranking points to Swiatek’s 7,970—a 1,046-point gap.

The tennis world awoke to a surprise on Monday, with Aryna Sabalenka replacing Iga Swiatek as No. 1 in the WTA rankings. Sabalenka, who has won two Grand Slam titles in a sterling season ...

Iga Swiatek will enter the tournament aiming to defend her title after beating Jessica Pegula in straight sets during last year's final. The battle between Swiatek and Aryna Sabalenka for the ...

Valley store still open 24/7, others to close at 10 p.m.; Kenny’s Liquor Market still open for now. This is a developing story. Breeze In’s three convenience stores and catering operation have ...

The final draw of the WTA season has been revealed, world No. 1 Aryna Sabalenka and No. 2 Iga Swiatek headlining their respective round robin groups at the 2024 WTA Finals. Sabalenka, who returned ...

PHOTOS: Whites Road in southern Kalamazoo reopens to traffic Drivers were advised just after 1:30 p.m. to find alternate routes until further notice after Parkview Avenue at South 12th Street shut ...

IgA nephropathy is an autoimmune kidney disease, and complement, a component of the innate immune system, plays a role in the condition's pathogenesis. Investigators have developed and tested a ...

(RTTNews) - Travere Therapeutics Inc. (TVTX) announced that new data further demonstrates the clinical benefit of FILSPARI (sparsentan) in IgA nephropathy (IgAN) and reinforces its potential in ...

IgA nephropathy (IgAN) is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their surface. A recent Phase 2 trial revealed that felzartamab, an ...

FORT WAYNE, Ind. (WANE) — Just one week after an investigative reporter with The Guardian U.S. blasted Parkview Health, writing it “took over a region and jacked up prices,” the online ...